202 related articles for article (PubMed ID: 14704849)
1. Retention of atherogenic lipoproteins in atherogenesis.
Gustafsson M; Flood C; Jirholt P; Borén J
Cell Mol Life Sci; 2004 Jan; 61(1):4-9. PubMed ID: 14704849
[TBL] [Abstract][Full Text] [Related]
2. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis.
Skålén K; Gustafsson M; Rydberg EK; Hultén LM; Wiklund O; Innerarity TL; Borén J
Nature; 2002 Jun; 417(6890):750-4. PubMed ID: 12066187
[TBL] [Abstract][Full Text] [Related]
3. Role of extracellular retention of low density lipoproteins in atherosclerosis.
Borén J; Gustafsson M; Skålén K; Flood C; Innerarity TL
Curr Opin Lipidol; 2000 Oct; 11(5):451-6. PubMed ID: 11048887
[TBL] [Abstract][Full Text] [Related]
4. Nonoxidative modifications of lipoproteins in atherogenesis.
Tabas I
Annu Rev Nutr; 1999; 19():123-39. PubMed ID: 10448519
[TBL] [Abstract][Full Text] [Related]
5. The response-to-retention hypothesis of atherogenesis reinforced.
Williams KJ; Tabas I
Curr Opin Lipidol; 1998 Oct; 9(5):471-4. PubMed ID: 9812202
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein B: a clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosis.
Olofsson SO; Borèn J
J Intern Med; 2005 Nov; 258(5):395-410. PubMed ID: 16238675
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of lipoprotein retention by the extracellular matrix.
Gustafsson M; Borén J
Curr Opin Lipidol; 2004 Oct; 15(5):505-14. PubMed ID: 15361785
[TBL] [Abstract][Full Text] [Related]
8. The NH2-terminal region of apolipoprotein B is sufficient for lipoprotein association with glycosaminoglycans.
Goldberg IJ; Wagner WD; Pang L; Paka L; Curtiss LK; DeLozier JA; Shelness GS; Young CS; Pillarisetti S
J Biol Chem; 1998 Dec; 273(52):35355-61. PubMed ID: 9857078
[TBL] [Abstract][Full Text] [Related]
9. Apolipoproteins, the lipid hypothesis and ischaemic heart disease.
Avogaro P
Przegl Lek; 1985; 42(8):602-6. PubMed ID: 4089215
[No Abstract] [Full Text] [Related]
10. Lipoproteins, apolipoproteins and coronary artery disease.
Fruchart JC; Parra H; Cachera C; Clavey V; Bertrand M
Ric Clin Lab; 1982; 12(1):101-6. PubMed ID: 6806881
[No Abstract] [Full Text] [Related]
11. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications.
Tabas I; Williams KJ; Borén J
Circulation; 2007 Oct; 116(16):1832-44. PubMed ID: 17938300
[TBL] [Abstract][Full Text] [Related]
12. Apoproteins B and A-I and coronary artery disease in humans.
Brunzell JD; Sniderman AD; Albers JJ; Kwiterovich PO
Arteriosclerosis; 1984; 4(2):79-83. PubMed ID: 6422918
[No Abstract] [Full Text] [Related]
13. Identification of the proteoglycan binding site in apolipoprotein B48.
Flood C; Gustafsson M; Richardson PE; Harvey SC; Segrest JP; Borén J
J Biol Chem; 2002 Aug; 277(35):32228-33. PubMed ID: 12070165
[TBL] [Abstract][Full Text] [Related]
14. Workshop on the impact of dietary cholesterol on plasma lipoproteins and atherogenesis.
Grundy SM; Barrett-Connor E; Rudel LL; Miettinen T; Spector AA
Arteriosclerosis; 1988; 8(1):95-101. PubMed ID: 3341995
[No Abstract] [Full Text] [Related]
15. [Experimental atherogenesis in the Wistar rat].
Aubert D; Ferrand JC; Lacaze B; Pepin O; Panak E; Podesta M
Atherosclerosis; 1974; 20(2):263-80. PubMed ID: 4369561
[No Abstract] [Full Text] [Related]
16. [Hereditary changes of apolipoproteins B and E].
Gaeta G; Effuso L; Maurea N; Boccalatte M; Antignano A; Sifola C; Scala R
Clin Ter; 1994 Jun; 144(6):527-37. PubMed ID: 8001338
[TBL] [Abstract][Full Text] [Related]
17. The role of native apolipoprotein B-containing lipoproteins in atherosclerosis: cellular mechanisms.
Sehayek E; Eisenberg S
Curr Opin Lipidol; 1994 Oct; 5(5):350-3. PubMed ID: 7858909
[TBL] [Abstract][Full Text] [Related]
18. [Why are plasmatic apoB lipoproteins atherogenic? The hypothesis of response to retention].
Hurt-Camejo E; Camejo G
Invest Clin; 2001 May; 42 Suppl 1():43-73. PubMed ID: 11416984
[TBL] [Abstract][Full Text] [Related]
19. [Age-specific changes of glycosaminoglycan and lipid content of blood in coronary arteriosclerosis].
Kasatkina LV; Shtel'makh NI; Kovaleva ON
Kardiologiia; 1974 Oct; 14(10):103-6. PubMed ID: 4280465
[No Abstract] [Full Text] [Related]
20. Lipoproteins and atherogenesis. Current concepts.
Steinberg D; Witztum JL
JAMA; 1990 Dec; 264(23):3047-52. PubMed ID: 2243434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
